Table 1. The basic characteristics and their individual F statistics for selected summary level GWASs applied in our MR study.
Trait | Sample size | Sex | First author/consortium | F statistics |
---|---|---|---|---|
Overall C-reactive protein (CRP) | 310,305 | Males and females | – | 3,135.39 |
East Asian-specific CRP variants | 75,391 | Males and females | Ishigaki K | 762.53 |
Hispanic/Latin American-specific CRP variants | 15,912 | Males and females | Wojcik GL | 161.73 |
European-specific CRP variants | 204,402 | Males and females | Neale lab | 2,065.67 |
African American/Afro-Caribbean-specific CRP variants | 6,203 | Males and females | Pan-UKB team | 63.66 |
South Asian-specific CRP variants | 8,397 | Males and females | Pan-UKB team | 85.82 |
Lung cancer | 27,209 | Males and females | ILCCO | 275.84 |
Lung adenocarcinoma | 18,336 | Males and females | ILCCO | 186.21 |
Squamous cell lung cancer | 18,313 | Males and females | ILCCO | 185.98 |
ILCCO, the International Lung Cancer Consortium.